Eiko Lifesciences Ltd vs Multibase India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 20, 2026

Key Highlights

The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 52.96 as of 20 Mar 12:17 . The P/E Ratio of Eiko Lifesciences Ltd is 31.1 as of March 2025 .The P/E Ratio of Multibase India Ltd is 0 as of March 2025 . The Market Cap of Eiko Lifesciences Ltd is ₹ 65.15 crore as of March 2025 .The Market Cap of Multibase India Ltd is ₹ 0 crore as of March 2025 . The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of Multibase India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of Multibase India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The net profit of Multibase India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Multibase India Ltd changed from 37.56 % on March 2021 to 456.56 % on March 2025 . This represents a CAGR of 64.80% over 5 years .

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

About Multibase India Ltd

Multibase India Limited was incorporated as Synergy Polymers Limited on 17th December, 1991.
In 1999, the name of Company was changed to Synergy Mulitibase Limited and further to Multibase India Limited on August 31, 2007. Multibase India Ltd is part of the Multibase SA Group, a leading compounder in Europe, the USA and India.
In 2002, the Company was acquired by Multibase SA, subsidiary of Dow Corning Corporation and thus became a Dow corning Company. The company is engaged in in manufacturing, trading and selling of polypropylene compound, thermoplastic elastomer, silicon master batch and thermoplastic master batch.
It is a diverse yet integrated manufacturing company of thermoplastic elastomers and silicone-based products. The Company's products include Silicon-Based Thermoplastics, TPSiV Multiplex, Thermoplastic-Elastomer (TPE physically blends), Triethyl silane (TES) Multiplex Range of Products.

FAQs for the comparison of Eiko Lifesciences Ltd and Multibase India Ltd

Which company has a larger market capitalization, Eiko Lifesciences Ltd or Multibase India Ltd?

Market cap of Eiko Lifesciences Ltd is 75 Cr while Market cap of Multibase India Ltd is 358 Cr

What are the key factors driving the stock performance of Eiko Lifesciences Ltd and Multibase India Ltd?

The stock performance of Eiko Lifesciences Ltd and Multibase India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Eiko Lifesciences Ltd and Multibase India Ltd?

As of March 20, 2026, the Eiko Lifesciences Ltd stock price is INR ₹52.7. On the other hand, Multibase India Ltd stock price is INR ₹283.8.

How do dividend payouts of Eiko Lifesciences Ltd and Multibase India Ltd compare?

To compare the dividend payouts of Eiko Lifesciences Ltd and Multibase India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.